Morais, C.M., Cardoso, A.M., Aguiar, L., Vale, N., Nóbrega, C., Zuzarte, M., Gomes, P., Pedroso de Lima, M.C. and Jurado, A.S. (2020). Lauroylated histidine-enriched S413-PV peptide as an efficient gene silencing mediator in cancer cells. Pharmaceutical Research 37, 188-206. https://doi.org/10.1007/s11095-020-02904-x.
Cardoso, A.M., Sousa, M., Morais, C.M., Oancea-Castillo, L.R., Régnier-Vigouroux, A., Rebelo, O., Tão, H., Barbosa, M., Pedroso de Lima, M.C., and Jurado, A.S. (2019). MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy. Human Molecular Genetics, 28, 2738-2751. https://doi.org/10.1093/hmg/ddz099.
Morais, C.M., Cunha, P.P., Melo, T., Cardoso, A.M., Domingues, P., Domingues, M.R., Pedroso de Lima, M.C. and Jurado, A.S. (2019). Glucosylceramide synthase silencing is detrimental to glioblastoma cells when combined with axitinib. Human Molecular Genetics, 28, 3664-3679 https://doi.org/10.1093/hmg/ddz152.
Morais, C.M., Cardoso, A.M., Cunha, P.P., Aguiar, L., Vale, N., Lage, E., Pinheiro, M., Nunes, C., Gomes, P., Reis, S., Castro, M.M.C.A., Pedroso de Lima, M.C, and Jurado, A.S. (2018). Acylation of the S413-PV cell-penetrating peptide as a means of enhancing its capacity to mediate nucleic acid delivery: Relevance of peptide/lipid interactions. Biochimica et Biophysica Acta Biomembranes, 1860(12), 2619-2634. https://doi.org/10.1016/j.bbamem.2018.10.002.
Cunha, P.P., Costa, P.M., Morais, C.M., Lopes, I.R., Cardoso, A.M., Cardoso, A.L., Mano, M., Jurado, A.S., and Pedroso de Lima, M.C. (2017). High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors. Human Molecular Genetics, 26(22), 4375-4387. https://doi.org/10.1093/hmg/ddx323
Viegas, A.T., Guedes, J., Oliveira, A.R., Cardoso, A.M., and Cardoso, A.L. (2017). MiRNAs: New Biomarkers and Therapeutic Targets in Dementia. Current Pharmaceutical Design, 23 (5), 669-692. https://doi.org/10.2174/1381612823666170111094702.
Conceição, M., Mendonça, L., Nóbrega, C., Gomes, C., Costa, P., Hirai, H., Moreira, J.N., Pedroso de Lima, M.C., Manjunath, N., Almeida, and L.P. (2016). Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype. Biomaterials, 82, 124-137. https://doi.org/10.1016/j.biomaterials.2015.12.021
Cardoso A.M, Guedes, J., Cardoso, A.L., Morais, C., Cunha, P., Viegas, A.T., Costa, R., Jurado A.S. and M.C. Pedroso de Lima, M.C. (2016). Recent trends in nanotechnology toward CNS diseases: Lipid-based nanoparticles and exosomes for targeted therapeutic delivery, In K. Al-Jamal (Ed) International Review of Neurobiology: Nanotechnology and the Brain, Elsevier, 130, 1-40. https://doi.org/10.1016/bs.irn.2016.05.002
Costa, P.M, Cardoso, A.L., Mano, M., Pedroso de Lima, M.C. (2016) MicroRNAs in glioblastoma: Role in pathogenesis and opportunities for targeted therapies. CNS & Neurological Disorders-Drug Targets, 14, 222-238. https://doi.org/ 10.2174/1871527314666150116123610
Costa P.M., Cardoso A.L., Custódia C., Cunha P., Pereira de Almeida L. and Pedroso de Lima M.C. (2015). MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma. Journal of Controlled Release, 207, 31-39. https://doi.org/10.1016/j.jconrel.2015.04.002
|